CCL5 and chronic kidney disease: In this study, we examined CCL5 expression in human glomerular diseases and in a CKD mouse model of adriamycin-induced (ADR-induced) nephropathy, which mimics FSGS — the primary cause of primary glomerular diseases leading to CKD (12, 13).